Tag: Interleukin inhibitors

Approved by the FDA in 2019 for the treatment of moderate-to-severe plaque psoriasis, many people wonder: **What is the generic name for Skyrizi?** The active ingredient for this widely-used biologic is risankizumab-rzaa.

Approved by the FDA in 2017, benralizumab is a biologic medication designed for the add-on maintenance treatment of severe eosinophilic asthma. This article explains **what class of drug is benralizumab** and its unique mechanism of targeting the interleukin-5 (IL-5) receptor to reduce eosinophil-driven inflammation.

The global interleukin inhibitors market is projected to reach significant valuation by 2032, highlighting their critical and growing role in modern medicine. But what is an interleukin inhibitor, and how do these advanced biologic therapies function to treat chronic inflammatory conditions?